Working… Menu

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00324558
Recruitment Status : Terminated (Sponsor stopped due to difficulties to recruit 130 patients required by protocol)
First Posted : May 11, 2006
Last Update Posted : June 8, 2012
Information provided by (Responsible Party):
Clinica Universidad de Navarra, Universidad de Navarra